Drug Trial Radar · NCT01199263
Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Last checked: Nov 19, 2026Latest source record: Sep 16, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
108
Actual
Start
Dec 6, 2010
Primary completion
Jun 1, 2015
Study completion Jul 17, 2020
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- Collaborators
- NRG Oncology
- First posted
- Sep 10, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase II trial studies the side effects and how well giving paclitaxel with or without viral therapy works in treating patients with ovarian epithelial, fallopian tube, or primary peritoneal cancer that has come back. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them spreading. Viral therapy may be able to kill tumor cells without damaging normal cells. Giving paclitaxel together with viral therapy may kill more tumor cells.
Conditions
- Recurrent Fallopian Tube Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Primary Peritoneal Carcinoma
Interventions
Laboratory Biomarker AnalysisOther
Correlative studies
PaclitaxelDrug
Given IV
PelareorepBiological
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free Survival (PFS)Time frame: Approximately 4.5 years.
- Number of Participants With Adverse Events Grade 3 or Greater as Assessed by CTCAE Version 4.0Time frame: approximately 4.5 years
Locations
36 sites in 1 country. Site status is shown where the registry gives one.
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California
Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut
Northeast Georgia Medical Center-Gainesville
Gainesville, Georgia
Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho
Indiana University/Melvin and Bren Simon Cancer Center
Indianapolis, Indiana
Michigan Cancer Research Consortium NCORP
Ann Arbor, Michigan
Saint Joseph Mercy Hospital
Ann Arbor, Michigan
Beaumont Hospital - Dearborn
Dearborn, Michigan
Ascension Saint John Hospital
Detroit, Michigan
Hurley Medical Center
Flint, Michigan
Genesys Regional Medical Center
Grand Blanc, Michigan
Allegiance Health
Jackson, Michigan
Sparrow Hospital
Lansing, Michigan
Saint Mary Mercy Hospital
Livonia, Michigan
Saint Joseph Mercy Oakland
Pontiac, Michigan
Lake Huron Medical Center
Port Huron, Michigan
Ascension Saint Mary's Hospital
Saginaw, Michigan
Saint John Macomb-Oakland Hospital
Warren, Michigan
Mayo Clinic in Rochester
Rochester, Minnesota
University of Mississippi Medical Center
Jackson, Mississippi
Women's Cancer Center of Nevada
Las Vegas, Nevada
University of New Mexico Cancer Center
Albuquerque, New Mexico
Atrium Health Cabarrus/LCI-Concord
Concord, North Carolina
Wake Forest University Health Sciences
Winston-Salem, North Carolina
Case Western Reserve University
Cleveland, Ohio
Cleveland Clinic Cancer Center/Fairview Hospital
Cleveland, Ohio
Cleveland Clinic Foundation
Cleveland, Ohio
Ohio State University Comprehensive Cancer Center
Columbus, Ohio
Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio
UH Seidman Cancer Center at Lake Health Mentor Campus
Mentor, Ohio
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Women and Infants Hospital
Providence, Rhode Island
UT Southwestern/Simmons Cancer Center-Dallas
Dallas, Texas
Carilion Clinic Gynecological Oncology
Roanoke, Virginia
Medical College of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.